BB Biotech AG (BION)
SIX
Closed
Oct 8, 2026
Day's Range
47.6052 wk Range
37.25Overview - BION - BB Biotech AG
Key Statistics
Valuation
Enterprise Value
23.13M
P/E (Trailing)
‪2.28‬
P/E (Forward)
‪-85.44‬
PEG Ratio
‪-0.0080‬
Price / Sales (TTM)
‪2.92‬
Price / Book
‪1.00‬
Profitability
Profit Margin
‪127.31%‬
Operating Margin
‪97.74%‬
Return on Assets
‪25.87%‬
Return on Equity
‪54.76%‬
Ownership
Shares Outstanding
55.14M
Held by Insiders
‪0.07%‬
Held by Institutions
‪19.24%‬
Price stats
Beta
‪0.65‬
50-Day Avg
‪50.79‬
200-Day Avg
‪46.65‬
Dividends
Frequency
Annual
Analyst Consensus
2 analysts
Market Cap - BION - BB Biotech AG
Peers - BION - BB Biotech AG
Peer Comparison
Compared with companies in Biotechnology listed on SIX.
- BIONSIXBB Biotech AG3.08BMarket Cap+42.23%52-week change2.29P/E (Trailing)‪127.31%‬Profit Margin
- BSLNSIXBasilea Pharmaceutica Ltd851.32MMarket Cap+32.82%52-week change17.13P/E (Trailing)‪21.17%‬Profit Margin
- BIOVSIXBioVersys AG153.39MMarket Cap-8.78%52-week change-6.84P/E (Trailing)‪-386.62%‬Profit Margin
- ADXNSIXAddex Therapeutics Ltd3.73MMarket Cap-145.53%52-week change-0.41P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - BION - BB Biotech AG
About
BB Biotech AG is a Switzerland-based investment company specializing in the biotechnology sector. Founded in 1993 and headquartered in Schaffhausen, it invests primarily in publicly traded companies developing and commercializing innovative drugs that address significant unmet medical needs, such as oncology,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
